News

Hudson Institute was proud to host the announcement of the Victorian Paediatric Cancer Consortium (VPCC).…  Read more

Two Hudson Institute researchers have been made Associate Members of Australia’s leading health and medical science advocacy body, the Australian Academy of Health and Medical Sciences (AAHMS).…  Read more

A cell therapy could reduce inflammatory response in liver disease, offering hope to thousands of Australians suffering from the disease.…  Read more

A world-first study at Hudson Institute has taken a big step to understanding the causes of neonatal brain injury…  Read more

A researcher developing 3D bioprinted mesh for use in treating pelvic organ prolapse (POP) has received a Victoria Fellowship, allowing him to travel overseas to further his research into bioinks.…  Read more

A colon cancer research breakthrough at Hudson Institute has shown that combining two types of drugs targeting gene expression stops cancer proliferation.…  Read more

An international team developing new technologies for vaginal reconstruction has been awarded a prestigious million-dollar prize.…  Read more

A new understanding of the causes of small cell lung cancer (SCLC) could lead to more personalised treatments and lower mortality from this deadly disease.…  Read more

An ambitious project to identify and characterise the rarest and deadliest forms of brain cancer in children has received a welcome funding boost.…  Read more

Neural Stem Cells have strong potential to be effective in reducing brain injury in newborn babies, in the most extensive review of research on the topic.…  Read more